Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Allergy Clin Immunol. 2010 Nov;126(5):1000–1005. doi: 10.1016/j.jaci.2010.05.021

Table I.

Pre-transplant patient characteristics

Characteristic Patient 1 Patient 2
Age at
 Diagnosis   2 months   11 years
 HCT   9 months   16 years
IPEX features
 Immune dysregulation Eosinophilia (1000–2000/mm3) Eosinophilia (>2000/mm3)
Hyper-IgE (183 IU/mL) Hyper-IgE (842 IU/mL)
Anticardiolipin antibodies (DVT) Hypogammaglobulinemia (204 mg/dL)
Hemolytic anemia Anemia
Infections Infections
Membranous nephropathy
 Polyendocrinopathy Diabetes Diabetes
Hypothyroidism
Growth Hormone Deficiency
 Enteropathy Diarrhea Diarrhea
Failure to thrive Failure to thrive
 Other Steroid dependent interstitial lung disease
Osteopenia
Seizure disorder
FOXP3 gene
 Mutation* c.210_210+1GG>AC c.816+7G>C
 Mutation significance Abnormal mRNA splicing Abnormal mRNA splicing
 Protein expression Absent Reduced
Infections
 Bacterial Skin abscesses Recurrent pneumonias
 Staphylococcus aureus
 MRSA
Brain abscess
Sepsis
 Group A streptococcus
 Enterococcus Faecalis
 Coagulase negative
 Staphylococcus
 Fungal Fungemia Skin abscesses
 Candida albicans  Alternaria
 Viral Viremia Viremia
 Cytomegalovirus  Cytomegalovirus
 EBV
EBV-lymphoproliferative disorders of
lungs and intestinal tract
*

Mutation nomenclature per den Dunnan and Antonarakis.(25)

EBV, Epstein-Barr virus; HCT, hematopoietic cell transplantation; MRSA, methicillin-resistant Staphylococcus aureus